EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia

Denise M Smith, Michael L Niehoff, Karen Ling, Paymaan Jafar-Nejad, Frank Rigo, Susan A Farr, Miles F Wilkinson, Andrew D Nguyen iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0282822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Denise M Smith und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geriatric Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, United States of Ame…. Hauptthemen laut MEDLINE: Frontotemporal Dementia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NICHD NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A common cause of frontotemporal dementia (FTD) are nonsense mutations in the progranulin (GRN) gene. Because nonsense mutations activate the nonsense-mediated RNA decay (NMD) pathway, we sought to inhibit this RNA turnover pathway as a means to increase progranulin levels. Using a knock-in mouse model harboring a common patient mutation, we tested whether either pharmacological or genetic inhibition of NMD upregulates progranulin in these Grn R493X mice. We first examined antisense oligonucleotides (ASOs) targeting an exonic region in Grn R493X mRNA predicted to block its degradation by NMD. As we previously reported, these ASOs effectively increased Grn R493X mRNA levels in fibroblasts in vitro . However, following CNS delivery, we found that none of the 8 ASOs we tested increased Grn mRNA levels in the brains of Grn R493X mice. This result was obtained despite broad ASO distribution in the brain. An ASO targeting a different mRNA was effective when administered in parallel to wild-type mice. As an independent approach to inhibit NMD, we examined the effect of loss of an NMD factor not required for embryonic viability: UPF3b. We found that while Upf3b deletion effectively perturbed NMD, it did not increase Grn mRNA levels in Grn +/R493X mouse brains. Together, our results suggest that the NMD-inhibition approaches that we used are likely not viable for increasing progranulin levels in individuals with FTD caused by nonsense GRN mutations. Thus, alternative approaches should be pursued.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaMiceAnimalsProgranulinsRNACodon, NonsenseRNA, MessengerNonsense Mediated mRNA DecayDisease Models, AnimalRNA-Binding Proteins

Substanzen

ProgranulinsRNACodon, NonsenseRNA, MessengerGrn protein, mouseUPF3B protein, mouseRNA-Binding Proteins

Autor:innen und Institutionen

  • Division of Geriatric Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
  • Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
  • Institute for Translational Neuroscience, Saint Louis University, St. Louis, Missouri, United States of America.
  • Veterans Affairs Medical Center, St. Louis, Missouri, United States of America.
  • Ionis Pharmaceuticals, Carlsbad, California, United States of America.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, United States of America.

ORCID-Profile: Andrew D Nguyen

Förderung

  • NIA NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences
  • Bluefield Project to Cure FTD
  • Ionis Pharmaceuticals

Zitieren

APA

Smith, D. M., Niehoff, M. L., Ling, K., Jafar-Nejad, P., Rigo, F., Farr, S. A., Wilkinson, M. F., & Nguyen, A. D. (2023). Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia. PLOS ONE. https://doi.org/10.1371/journal.pone.0282822

Vancouver

Smith DM, Niehoff ML, Ling K, Jafar-Nejad P, Rigo F, Farr SA, et al. Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia. PLOS ONE. 2023. doi:10.1371/journal.pone.0282822

BibTeX
@article{Smith2023,
  author = {Smith, Denise M and Niehoff, Michael L and Ling, Karen and Jafar-Nejad, Paymaan and Rigo, Frank and Farr, Susan A and Wilkinson, Miles F and Nguyen, Andrew D},
  title = {Targeting nonsense-mediated RNA decay does not increase progranulin levels in the Grn R493X mouse model of frontotemporal dementia},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0282822}
}
Kostenlos starten →